Efficacy & Safety of XC8, Film-coated Tablets, in Children With Acute

See also
Status	Clinical Trial	Phase
Completed	`NCT03943654` - Improving Nighttime Access to Care and Treatment (Part 2)
Completed	`NCT05269290` - Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections	Phase 3
Completed	`NCT06385821` - A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus	Phase 3
Not yet recruiting	`NCT05902702` - Isotonic Saline for Children With Bronchiolitis	N/A
Not yet recruiting	`NCT04525118` - Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-based Study Platform
Completed	`NCT01431469` - Efficacy and Tolerance of a Follow-On Formula Fed to Children From 12-48 Months of Age in Salvador, Bahia, Brazil	N/A
Completed	`NCT00981513` - Direct and Indirect Benefits of Influenza Vaccination in Schools and Households	Phase 4
Recruiting	`NCT06183229` - Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza	Phase 3
Completed	`NCT03274310` - FluSAFE: Flu SMS Alerts to Freeze Exposure	N/A
Completed	`NCT03736096` - Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients
Completed	`NCT03189537` - Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections	Phase 3
Completed	`NCT03028077` - Effects of GS-3K8 and GINst15 on Acute Respiratory Illness	N/A
Enrolling by invitation	`NCT01286285` - Surveillance of Influenza in Paediatric Intensive Care Units in Bavaria	N/A
Completed	`NCT03840135` - Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged 1-12 Years With ARI	Phase 3
Completed	`NCT01488435` - Efficacy and Tolerance of a Follow-On Formula Fed to Children From 36-48 Months of Age	N/A
Not yet recruiting	`NCT00545961` - Middle Meatal Bacteriology During Acute Respiratory Infection in Children	Phase 4
Completed	`NCT05273619` - Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection	Phase 3
Recruiting	`NCT04415827` - Energy Supply in Athletes and Untrained Persons With Bronchopulmonary Diseases	N/A
Completed	`NCT03459391` - Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers	Phase 1
Withdrawn	`NCT04938323` - Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly	Phase 2/Phase 3

NCT number	NCT06379542
Study type	Interventional
Source	Valenta Pharm JSC
Contact
Status	Recruiting
Phase	Phase 3
Start date	December 4, 2023
Completion date	December 31, 2025

Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms